Atlas Trials

BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women.

Clinical trial NCT04880889 · UNKNOWN

Trial details

NCT number
NCT04880889
Sponsor
Biolab Sanus Farmaceutica
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Telogen Effluvium
Start date
2023-01-01
Primary completion
2023-07-30
Enrollment
326

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.